Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

Resorcylidene aminoguanidine induces antithrombotic action that is not dependent on its antiglycation activity.

Watala C, Dobaczewski M, Kazmierczak P, Gebicki J, Nocun M, Zitnanova I, Ulicna O, Durackova Z, Waczulíková I, Carsky J, Chlopicki S.

Vascul Pharmacol. 2009 Oct;51(4):275-83. doi: 10.1016/j.vph.2009.07.002. Epub 2009 Jul 24.

PMID:
19635586
[PubMed - indexed for MEDLINE]
2.

Aminoguanidine inhibits albuminuria, but not the formation of advanced glycation end-products in skin collagen of diabetic rats.

Degenhardt TP, Fu MX, Voss E, Reiff K, Neidlein R, Strein K, Thorpe SR, Baynes JW, Reiter R.

Diabetes Res Clin Pract. 1999 Feb;43(2):81-9.

PMID:
10221660
[PubMed - indexed for MEDLINE]
3.

L-Carnitine inhibits protein glycation in vitro and in vivo: evidence for a role in diabetic management.

Rajasekar P, Anuradha CV.

Acta Diabetol. 2007 Jun;44(2):83-90. Epub 2007 May 27.

PMID:
17530472
[PubMed - indexed for MEDLINE]
4.

Ilex paraguariensis extracts inhibit AGE formation more efficiently than green tea.

Lunceford N, Gugliucci A.

Fitoterapia. 2005 Jul;76(5):419-27.

PMID:
15894431
[PubMed - indexed for MEDLINE]
5.

Effects of resorcylidene aminoguanidine (RAG) on selected parameters of isolated rat liver mitochondria.

Labieniec M, Przygodzki T, Cársky J, Malinska D, Rysz J, Watala C.

Chem Biol Interact. 2009 May 15;179(2-3):280-7. doi: 10.1016/j.cbi.2008.11.005. Epub 2008 Nov 18.

PMID:
19061873
[PubMed - indexed for MEDLINE]
6.
7.

Collagen ultrastructure and TGF-beta1 expression preserved with aminoguanidine during wound healing in diabetic rats.

Yavuz D, Tuğtepe H, Cetinel S, Uyar S, Kaya H, Haklar G, Civelek S, Deyneli O, San T, Burçak G, Akalin S.

Endocr Res. 2005;31(3):229-43.

PMID:
16392625
[PubMed - indexed for MEDLINE]
8.

Fluidising effect of resorcylidene aminoguanidine on sarcolemmal membranes in streptozotocin-diabetic rats: blunted adaptation of diabetic myocardium to Ca2+ overload.

Waczulíková I, Ziegelhöffer A, Országhová Z, Cársky J.

J Physiol Pharmacol. 2002 Dec;53(4 Pt 2):727-39.

PMID:
12510859
[PubMed - indexed for MEDLINE]
Free Article
9.

Role of maltol in advanced glycation end products and free radicals: in-vitro and in-vivo studies.

Kang KS, Yamabe N, Kim HY, Yokozawa T.

J Pharm Pharmacol. 2008 Apr;60(4):445-52. doi: 10.1211/jpp.60.4.0006.

PMID:
18380916
[PubMed - indexed for MEDLINE]
10.

Inhibition of advanced protein glycation by a Schiff base between aminoguanidine and pyridoxal.

Taguchi T, Sugiura M, Hamada Y, Miwa I.

Eur J Pharmacol. 1999 Aug 13;378(3):283-9.

PMID:
10493104
[PubMed - indexed for MEDLINE]
11.

Aminoguanidine reduces regional albumin clearance but not urinary albumin excretion in streptozotocin-diabetic rats.

Huijberts MS, Wolffenbuttel BH, Crijns FR, Nieuwenhuijzen Kruseman AC, Bemelmans MH, Struijker Boudier HA.

Diabetologia. 1994 Jan;37(1):10-4.

PMID:
8150221
[PubMed - indexed for MEDLINE]
12.

Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.

Gardiner TA, Anderson HR, Stitt AW.

J Pathol. 2003 Oct;201(2):328-33.

PMID:
14517851
[PubMed - indexed for MEDLINE]
13.

Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation.

Tilton RG, Chang K, Hasan KS, Smith SR, Petrash JM, Misko TP, Moore WM, Currie MG, Corbett JA, McDaniel ML, et al.

Diabetes. 1993 Feb;42(2):221-32.

PMID:
7678825
[PubMed - indexed for MEDLINE]
14.

Influence of beta-resorcylidene aminoguanidine on selected metabolic parameters and antioxidant status of rats with diabetes mellitus.

Liptáková A, Cársky J, Ulicná O, Vancová O, Bozek P, Duracková Z.

Physiol Res. 2002;51(3):277-84.

PMID:
12234120
[PubMed - indexed for MEDLINE]
Free Article
15.

Aminoguanidine pyridoxal adduct is superior to aminoguanidine for preventing diabetic nephropathy in mice.

Miyoshi H, Taguchi T, Sugiura M, Takeuchi M, Yanagisawa K, Watanabe Y, Miwa I, Makita Z, Koike T.

Horm Metab Res. 2002 Jul;34(7):371-7.

PMID:
12189584
[PubMed - indexed for MEDLINE]
16.

Effect of aminoguanidine on optic nerve involvement in experimental diabetic rats.

Ino-ue M, Ohgiya N, Yamamoto M.

Brain Res. 1998 Aug 3;800(2):319-22.

PMID:
9685690
[PubMed - indexed for MEDLINE]
17.

Testis glutathione peroxidase and phospholipid hydroperoxide glutathione peroxidase activities in aminoguanidine-treated diabetic rats.

Unlüçerçi Y, Bekpinar S, Koçak H.

Arch Biochem Biophys. 2000 Jul 15;379(2):217-20.

PMID:
10898937
[PubMed - indexed for MEDLINE]
18.

Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts.

Thornalley PJ.

Arch Biochem Biophys. 2003 Nov 1;419(1):31-40. Review.

PMID:
14568006
[PubMed - indexed for MEDLINE]
19.

Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine.

Booth AA, Khalifah RG, Hudson BG.

Biochem Biophys Res Commun. 1996 Mar 7;220(1):113-9.

PMID:
8602828
[PubMed - indexed for MEDLINE]
20.

[Inhibition of lipid peroxidation in erythrocytes by aminoguanidine, resorcylidine aminoguanidine and their oxygen and sulfur analogs in diabetic rats].

Hrnciarová M, Cársky J, Jakuś V, Zlatos L, Kucharská J, Gvozdjáková A.

Bratisl Lek Listy. 1998 Jul;99(7):364-7. Slovak.

PMID:
9748726
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk